Practical Challenges of Implementing a New Patient-Reported Outcome (PRO) in Oncology Under the German Pharmaceutical Market Restructuring Act (AMNOG) - Results From a Qualitative Focus Group Study

MLA

Pauge, Sophie, et al. Practical Challenges of Implementing a New Patient-Reported Outcome (PRO) in Oncology Under the German Pharmaceutical Market Restructuring Act (AMNOG) - Results From a Qualitative Focus Group Study. Jan. 2022. EBSCOhost, https://doi.org/10.1016/j.jval.2022.09.1610.

APA

Pauge, S., Surmann, B., Züger, A., Richter, L., Mathies, V., Mehlis, K., Ernst, T., Greiner, W., Menold, N., & Winkler, E. (2022). Practical Challenges of Implementing a New Patient-Reported Outcome (PRO) in Oncology Under the German Pharmaceutical Market Restructuring Act (AMNOG) - Results From a Qualitative Focus Group Study. https://doi.org/10.1016/j.jval.2022.09.1610

Chicago

Pauge, Sophie, Bastian Surmann, A. Züger, L. Richter, V Mathies, K. Mehlis, T. Ernst, Wolfgang Greiner, N. Menold, and E. Winkler. 2022. “Practical Challenges of Implementing a New Patient-Reported Outcome (PRO) in Oncology Under the German Pharmaceutical Market Restructuring Act (AMNOG) - Results From a Qualitative Focus Group Study,” January. doi:10.1016/j.jval.2022.09.1610.